• 제목/요약/키워드: Fatty degeneration

검색결과 84건 처리시간 0.024초

두충잎 물추출물이 사염화탄소를 투여한 흰쥐의 간손상에 미치는 영향 (Effect of Eucommia ulmoides Leaf Water Extract on Hepatotoxicity of Carbon Tetrachloride-Induced Rats)

  • 전정례;박정륭
    • 한국식품영양과학회지
    • /
    • 제31권1호
    • /
    • pp.124-130
    • /
    • 2002
  • 두충잎의 생약 및 식품 자원으로서의 이용성을 증진시킬 목적으로 두충잎의 물추출물을 사염화탄소를 투여한 흰쥐의 간손상에 미치는 영향을 검토하기 위해, 정상군, 사염화탄소군, 두충잎 물추출액 투여군, 사염화탄소 처리 후 두충잎 물추출액을 투여한 군의 4개군으로 나누어 6주간 사육하여 얻은 결과는 다음과 같다. 혈청 중의 AST, ALT, LDH 활성은 사염화탄소 투여에 의해 현저히 증가하였으나 두충잎 물추출물을 함께 투여함으로 정상군과 수준으로 회복되었다. 한편 사염화탄소에 의해 증가된 혈청중의 ALP 활성은 두충잎 투여에 의해 유의성 있게 감소하지 않았다. 혈청 중의 중성지질, 총 콜레스테롤 함량과 LDL콜레스테롤의 함량은 사염화탄소군에서만 유의적인 증가를 나타내었을 뿐 나머지 각군간의 유의적인 차이는 없었다. 한편 혈청 중의 HDL콜레스테롤의 함량은 두충 단독 투여군 및 사염화탄소 투여 후 두충잎 투여군이 정상군 및 사염화탄소 단독 투여군들보다 유의적으로 높게 나타났다. 간조직 중의 총콜레스테롤, 총지질, 중성 지질의 함량은 사염화탄소에 의해 유의적인 증가를 나타내었으나 두충잎 물추출액의 투여로 인해 이들의 함량이 유의성 있는 감소는 관찰되지 않았다. 광학현미경에 의한 간소직 세포의 병리학적인 검사에서는 사염화탄소군에서 간손상시 나타나는 간조직의 지방변화, 풍선양 변성, 호산성 변성, 국소성 괴사, 부위별 괴사가 관찰되었으나 그후 두충잎 투여에서 변화가 나타나지 않아 간 손상이 회복되었음을 알 수 있었다. 이상의 결과에서 두충잎 열수 추출물은 $CCl_4$에 의해 손상된 간기능을 회복시키는데 효과가 있었으며, 특히 혈청지질 개선에 탁월한 효과가 있음을 알 수 있었다.

메치오닌 수산화물의 첨가가 남은 음식물의 보관 중 성상변화에 미치는 영향 (Effects of Methionine Hydroxy Analogue on changes of Characteristics of food wastes in Incubator)

  • 이현준;김현섭;정하연;강수원;기광석;조광근;조재순;홍중산;김명국;이홍구;최윤재
    • 유기물자원화
    • /
    • 제10권3호
    • /
    • pp.59-67
    • /
    • 2002
  • 이 시험은 현재 우리나라 환경문제 중 하나로서 큰 오염원으로 인식되고 있는 남은 음식물의 재활용과 사료로서의 이용성을 높이기 위한 보존재로서 MHA의 적정 사용량을 알아내기 위하여 실시하였다. 소규모 식당에서 발생하는 남은 음식물을 수집하여 methionine 수산화물(MHA)을 처리하여 $40^{\circ}C$ 인큐베이터안에서 40일동안 변화를 관찰하였다. MHA를 원물중량의 1%, 3%, 5% 첨가구를 두고 대조구와 비교하였다. 염도는 MHA 첨가량이 많아질수록 증가하는 경향이 있었으며(p<0.05) pH는 MHA의 첨가량이 많아질수록 낮아지는 경향을 보였다(p<0.05). 휘발성지방산함량에 있어서는 대조구는 30일 이후에 증가하는 경향을 보였고 MHA처리구는 1, 3, 5% 첨가구 모두 15일차까지 감소하고 이후 일정한 함량을 나타내었다. 암모니아태 질소함량은 MHA의 첨가수준이 높을수록 떨어지는 경향을 보였다(p<0.05). 시료의 외관상 변화는는 대조구에서 표면 곰팡이 발생과 연화정도가 심하게 나타내었으며, MHA 첨가구에서는 1%구에서는 표면의 얇은 곰팡이는 나타내었으나 내부는 변화를 보이지 않아 남은음식물의 고온상태에서의 변패 변질 방지를 위해 MHA를 1% 이상 첨가하면 효과가 있는 것으로 나타내었다.

  • PDF

Study of a 13-weeks, Repeated, Intramuscular Dose, Toxicity Test of Sweet Bee Venom in Sprague-Dawley Rats

  • Kang, Hyunmin;Lim, Chungsan;Kwon, Ki-Rok;Lee, Kwangho
    • 대한약침학회지
    • /
    • 제17권2호
    • /
    • pp.73-79
    • /
    • 2014
  • Objectives: This study was performed to analyze a 13-week repeated dose toxicity test of Sweet Bee Venom (SBV) extracted from bee venom and administered in Sprague-Dawley (SD) rats. Methods: Male and female 5-week-old SD rats were treated once daily with SBV (high-dosage group: 0.28 mg/kg; medium-dosage group: 0.14 mg/kg; or low-dosage group: 0.07 mg/kg) for 13 weeks. Normal saline was administered to the control group in a similar manner (0.2 mL/kg). We conducted clinical observations, body weight measurements, ophthalmic examinations, urinalyses, hematology and biochemistry tests, and histological observations using hematoxylin and eosin (H&E) staining to identify any abnormalities caused by the SBV treatment. Results: During this study, no mortality was observed in any of the experimental groups. Hyperemia and a movement disorder were observed around the area of in all groups that received SBV treatment, with a higher occurrence in rats treated with a higher dosage. Male rats receiving in the high-dosage group showed a significant decrease in weight during the treatment period. Compared to the control group, no significant changes in the ophthalmic parameters, the urine analyses, the complete blood cell count (CBC), and the biochemistry in the groups treated with SBV. Compared to the control group, some changes in organ weights were observed in the medium-and the high-dosage groups, but the low-dosage group showed no significant changes. Histological examination of thigh muscle indicated cell infiltration, inflammation, degeneration, and necrosis of muscle fiber, as well as fibrosis, in both the medium- and the high-dosage groups. Fatty liver change was observed in the periportal area of rats receiving medium and high dosages of SBV. No other organ abnormalities were observed. Conclusion: Our findings suggest that the No Observed Adverse Effect Level (NOAEL) of SBV is approximately 0.07 mg/kg in male and female SD rats.

Study on a 4-Week Recovery Test of Sweet Bee Venom after a 13-Week, Repeated, Intramuscular Dose Toxicity Test in Sprague-Dawley Rats

  • Kang, Hyunmin;Lim, Chungsan;Lee, Seungbae;Kim, Byoungwoo;Kwon, Kirok;Lee, Kwangho
    • 대한약침학회지
    • /
    • 제17권2호
    • /
    • pp.18-26
    • /
    • 2014
  • Objectives: This study was performed to check for reversibility in the changes induced by a 13-week, repeated, dose toxicity test of Sweet Bee Venom (SBV) in Sprague-Dawley (SD) rats. Methods: Fifteen male and 15 female SD rats were treated with 0.28 mg/kg of SBV (high-dosage group) and the same numbers of male and female SD rats were treated with 0.2 mL/kg of normal saline (control group) for 13 weeks. We selected five male and five female SD rats from the high-dosage group and the same numbers of male and female SD rats from the control group, and we observed these rats for four weeks. We conducted body-weight measurements, ophthalmic examinations, urinalyses and hematology, biochemistry, histology tests. Results: (1) Hyperemia and movement disorder were observed in the 13-week, repeated, dose toxicity test, but these symptoms were not observed during the recovery period. (2) The rats in the high-dose group showed no significant changes in weight compared to the control group. (3) No significant differences in the ophthalmic parameters, urine analyses, complete blood cell counts (CBCs), and biochemistry were observed among the recovery groups. (4) No changes in organ weights were observed during the recovery period. (5) Histological examination of the thigh muscle indicated cell infiltration, inflammation, degeneration, necrosis of muscle fiber, and fibrosis during the treatment period, but these changes were not observed during the recovery period. The fatty liver change that was observed during the toxicity test was not observed during the recovery period. No other organ abnormalities were observed. Conclusion: The changes that occurred during the 13-week, repeated, dose toxicity test are reversible, and SBV can be safely used as a treatment modality.

Effect of Lactobacillus rhamnosus hsryfm 1301 on the Gut Microbiota and Lipid Metabolism in Rats Fed a High-Fat Diet

  • Chen, Dawei;Yang, Zhenquan;Chen, Xia;Huang, Yujun;Yin, Boxing;Guo, Feixiang;Zhao, Haiqing;Huang, Jiadi;Wu, Yun;Gu, Ruixia
    • Journal of Microbiology and Biotechnology
    • /
    • 제25권5호
    • /
    • pp.687-695
    • /
    • 2015
  • Accumulating evidence indicates that lactic acid bacteria could improve host physiology and lipid metabolism. To investigate the effect of the gut microbiota on host lipid metabolism, a hyperlipidemic rat model was established by feeding rats a high-fat diet for 28 days, and the gut microbiota of the rats was analyzed using real-time PCR before and after administration of Lactobacillus rhamnosus hsryfm 1301 and its fermented milk for 28 days. The findings showed that the Lactobacillus spp., Bifidobacterium spp., Bacteroides spp., and Enterococcus spp. content in the hyperlipidemic rats gut was increased significantly (p < 0.05), while the Clostridium leptum and Enterobacter spp. content was decreased significantly after intervening with L. rhamnosus hrsyfm 1301 and its fermented milk for 28 days (p < 0.05). Furthermore, the lipid levels of the serum and the liver were decreased significantly (p < 0.05) and the fecal water content was increased significantly (p < 0.05) in the hyperlipidemic rats after the intervention, and hepatocyte fatty degeneration of liver tissues was also prevented. A positive correlation was observed between the Clostridium leptum content and the level of serum cholesterol, triglycerides, low-density lipoprotein, and high-density lipoprotein, and a negative correlation was observed between the Enterobacter spp. content and the Lactobacillus spp. and Bifidobacterium spp. content in the hyperlipidemic rats gut. These results suggest that the gut microbiota and lipid metabolism of hyperlipidemic rats could be improved by supplementation with L. rhamnosus hsryfm 1301 and its fermented milk.

Sarcopenia: Nutrition and Related Diseases

  • Du, Yang;No, Jae Kyung
    • 한국조리학회지
    • /
    • 제23권1호
    • /
    • pp.66-78
    • /
    • 2017
  • "Sarcopenia", sarcopenia is an old age syndrome, and used to describe the reduction of skeletal muscle. Initially, it was thought that sarcopenia was only a senile disease characterized by degeneration of muscle tissue. However, its cause is widely regarded as multifactorial, with neurological decline, hormonal changes, inflammatory pathway activation, declines in activity, chronic illness, fatty infiltration, and poor nutrition, all shown to be contributing factors. Skeletal muscle mass can be measured by a variety of methods, currently, the commonly used methods are dual-energy X-ray scanning (DXA), computer tomography (CT), magnetic resonance imaging (MRI), etc. Muscular skeletal disorders can also be assessed by measuring appendicular skeletal muscle (ASM), particularly muscle tissue content. At the same time, sarcopenia refers to skeletal muscle cell denervation, mitochondrial dysfunction, inflammation, hormone synthesis and secretion changes and a series of consequences caused by the above process and is a progressive loss of skeletal muscle syndrome, which can lead to the decrease of muscle strength, physical and functional disorders, and increase the risk of death. Sarcopenia is mainly associated with the aging process, but also related to other causes such as severe malnutrition, neurodegenerative diseases, and disuse and endocrine diseases associated with muscular dystrophy, and it is the comprehensive results of multi-factors, so it is difficult to define that sarcopenia is caused by a specific disease. With the aging problem of the population, the incidence of this disease is increasingly common, and seriously affects the quality of the life of the elderly. This paper reviews the etiology and pathogenesis of myopathy, screening methods and diagnosis, the influence of eating habits, etc, and hopes to provide reference for the diagnosis and treatment of this disease. At present, adequate nutrition and targeted exercise remain the gold standard for the therapy of sarcopenia.

좌측상지에 발생한 선천성편비대 1례보고(증례보고) (Congenital Hemihypertrophy of Upper Extremity (A Case Report))

  • 최창혁;권굉우;김신근;이상욱;김경호;박재복
    • Clinics in Shoulder and Elbow
    • /
    • 제1권1호
    • /
    • pp.139-145
    • /
    • 1998
  • This report describes a rare, congenital hypertrophy of the left upper extremity that appeared after compressive bandage of right arm at the age of two. He is eighteen years old, and hypertrophy was aggravated for about 2 years since he started weight training exercise. Recently, skin turgor changed and he visited the Dermatology department. Skin biopsy revealed increased thickness of the dermis. On Orthopaedic examination, the left arm showed non­specific neuro-muscular changes other than easy fatigability a.nd increased skin consistency after exercise, compared to the right arm. The differences of circumference were 2.5 to 4cm according to the level of the upper limb. But the relative proportion of hypertrophy of the limb was balanced., On X-ray examination, bony changes were not shown. Through the MRI, we could find edematous changes of subcutaneous fatty tissue. Muscular structures showed unremarkable changes. Through the endurance test of both arms, we could find a decrease in endurance of the left upper arm musculatures. On histologic examination, infrequent focal necrosis and peri fascicular degeneration of the muscle fiber were present.

  • PDF

반복적인 얕은손가락굽힘근힘줄 폐쇄성 손상 후 발생한 방아쇠 손가락 증례 (A Case of Trigger Finger Following Longitudinal Tear of Flexor Digitorum Superficialis after Repeated Closed Injury)

  • 최환준;최의철;김용배
    • Archives of Plastic Surgery
    • /
    • 제37권3호
    • /
    • pp.304-308
    • /
    • 2010
  • Purpose: Many causes for triggering or locking of the fingers have been discussed in other literatures. The most common one is known stenosing tenosynovitis, which causes, a mismatch between the volume of the flexor tendon sheath and its contents. However, repeated trauma to the hand is uncommon cause of trigger finger. Therefore, we present a case of a rare condition of stenosing tenosynovitis which developed from a repeated relatively weak superficial flexor tendon injury. Methods: The patient was a 62-year-old woman who showed a painless, fixed and round mass on her right hand with no particular cause. Active and passive range of motion of the metacarpophalangeal joint of long finger was limited in flexion and extension. Ultrasonographic finding showed injured flexor digitorum superficialis tendon had fibrillar architecture with swelling between hyperechoic synovial membrane and hypoechoic surrounding area. Surgical exploration revealed that a bunched portion of the flexor digitorum superficialis and A1 pulley cause triggering during operation after adhesiolysis of scar tissue. Results: After releasing the A1 pulley, the range of motion of the metacarpophalangeal joint of long finger showed no limitation and histological examination of the subcutaneous tissue revealed fibrous fatty degeneration. In this case, releasing the A1 pulley with adhesiolysis of the subcutaneous scar tissue was successful and we obtained good functional outcome. Conclusion: We examined a patient in whom a repetitive impact forces to the palm caused longitudinal tear of the flexor tendon, leading to trigger finger. We experienced a rare case of stenosing tenosynovitis and trigger finger caused after close injury to flexor digitorum superficialis and its degenerative changes that caused mass like effect. To the best of authors' knowledge, our case of close injury to the flexor digitorum superficialis and unique morphologic change before rupture of tendon is rarely to be reported.

Biochemical and Histopathological Study of Aflatoxicosis on Ross 308 Broiler Chicks

  • Ko, Myung-Soon;Ahn, Meejung;Shin, Dong-Jin;Son, Youngho
    • 한국가금학회지
    • /
    • 제44권4호
    • /
    • pp.283-290
    • /
    • 2017
  • Totally, one hundred and sixty 1-day-old Ross 308 broiler chicks were fed with a diet containing 0, 0.5, 1.0, and 2.0 mg of aflatoxin $B_1(AFB_1)/kg$ of feed for 21 days. Body weight was lower for the $AFB_1$-treated broilers than for the control group. At 14 and 21 DPF, the broilers fed with 2.0 mg of $AFB_1/kg$ of feed weighed significantly lower than those of the other groups (p<0.05). Relative liver weights increased significantly in a dose-dependent manner, and relative spleen weights were significantly high in the chicks fed with 2.0 mg of $AFB_1/kg$ of feed at 21 DPF (p<0.001). Biochemical analyses showed that total protein and albumin levels decreased significantly at 7 and 14 DPF for the chicks of the group fed with 2.0 of mg $AFB_1/kg$ of feed, compared with those fed with 0.5 and 1.0 mg of $AFB_1/kg$ of feed (p<0.05). AST and ALT levels increased significantly at 14 and 21 DPF (p<0.05), and the AST levels, particularly, increased dose-dependently (p<0.05). Histopathological analyses showed that the liver tissues of the $AFB_1$-treated chicks showed significant lesions, including hemorrhage, hepatocyte necrosis, inflammatory cell infiltration, and fatty degeneration. The severity of both hepatocyte necrosis and inflammatory cell infiltration appeared to increase dose- and time-dependently. Similarly, hepatic fibrosis increased dose-dependently (p<0.05). The results of this study could improve our understanding of parameters used for evaluating aflatoxicosis in poultry.

고지방식이유도 실험용 Rat에서 Statin 및 한약 2종(후박, 하수오) 투여에 따른 혈중 지질, 조직 변화 비교 연구 (Dyslipidemic Effect of Pravastatin and Herbal Medicine in Rats)

  • 박성운;서윤정;최현정;유재환
    • 대한한방내과학회지
    • /
    • 제38권3호
    • /
    • pp.327-335
    • /
    • 2017
  • Objective: The goal of this preclinical study was to compare the dyslipidemic effect of pravastatin with that of herbal medicine in rats. Methods: In total, 40 rats were divided into 4 groups: Normal (10 rats), Control (10 rats), Statin alone (10 rats), and the MO-PM-S group (10 rats), which was given the powder of the cortex of Magnolia officinalis Rehd. et Wils., the root of Polygonum multiflorum Thunb, and pravastatin. The Control group, the Statin alone group, and the MO-PM-S group were all given a high-fat (45%) diet that made them obese. After 2 weeks of drug administration, the dyslipidemic effect of pravastatin was compared with that of herbal medicine in rats by analyzing the lipid profiles, measuring the body weights, and taking biopsies (liver, aorta). Results: The herbal medicine and the statin complex group got a much lower TG level and a slightly higher HDL-cholesterol level than the other groups. However, it got a higher total cholesterol and LDL-cholesterol level than the other groups. In biopsies, 30% of the Statin alone group and 10% of the MO-PM-S group showed mild histopathologic findings in the liver. Conclusion: The cortex of the Magnolia officinalis Rehd. et Wils. and the root of Polygonum multiflorum Thunb have dyslipidemic effects from the perspective of a TG level and HDL-cholesterol. However, the herbal mixture has a raising effect on both the LDL-cholesterol and the total cholesterol levels. Therefore, we cannot conclude that the herbal mixture helps to prevent dyslipidemia. In liver biopsies, the group administered with both the herbal mixture and the statin showed less histopathologic findings than the group administered with statin alone. This means that the herbal mixture helps to prevent fatty degeneration of the liver.